Posted in | News | Fibre Optics

Avensys Corp. to Divest its Fiber Optic Manufacturing Unit

Avensys Corporation (Pink Sheets: AVNY; FRANKFURT WKN: A0M9YA) today announced it has entered into a share purchase agreement to sell Avensys Inc., a wholly-owned subsidiary of Avensys Corporation and leading manufacturer and distributor of fiber optic components and integrator of instrumentation and turn-key systems for environmental monitoring, to 3S PHOTONICS, a world-leading French manufacturer of optical and optoelectronic components for telecommunications networks.

Upon the close of the sale, the assets of Avensys Inc.'s two divisions, Avensys Tech and Avensys Solutions, and the assets of ITF Laboratories Inc., will be merged with 3S PHOTONICS, based in Nozay, (Essonne near Paris), France. The closing of the sale is subject to customary closing conditions under the share purchase agreement and the approval by shareholders holding a majority of the shares held by shareholders attending a shareholders' meeting expected to be convened in January 2010. In connection with the transaction, Avensys Corporation has agreed to issue 105 million shares to Imperium Master Fund Ltd. in consideration for it forbearing from exercising its rights, arising from Avensys' continuing defaults under its debt agreements, until completion and agreeing to vote in favor of the transaction at the shareholders meeting. The cash consideration for the shares will be used to repay the amount of about $7.3 million owing to Imperium Master Fund Ltd. and to provide for other liabilities.

3S PHOTONICS is the leading world supplier of laser chips, discrete modules and optical components for undersea telecommunication networks. The acquisition of Avensys Inc. by 3S PHOTONICS is expected to result in a business, operating in both North America and Europe, with exceptional product synergies and a significantly greater ability to expand product lines and services beyond current capabilities. In the optical products and services space, the combined strength of the Avensys Tech division of Avensys Inc. and 3S PHOTONICS will enable the consolidated entity to respond even more effectively to the needs of its large industrial customers. For the Avensys Solutions division of Avensys Inc., consolidation with 3S PHOTONICS broadens access to international markets where increased environmental regulation and wider recognition of the value of sustainable development present growth opportunities for the company's products and services.

"Given Avensys' continuing default under its financing agreements, Avensys' Board of Directors concluded that the transaction was the best possible solution for the business," said John Fraser, CEO of Avensys Corporation. "Furthermore, combining the operations of two businesses with leading-edge and complementary technologies maximizes technological synergies, operational consolidation and opens up bigger market prospects for Avensys Inc. and 3S PHOTONICS."

"We are proud of this acquisition, which corresponds to the implementation of the external growth strategy that we planned last July, when we raised funds. We are also delighted to welcome such a great company, armed with know-how which will complement our own, and to establish links across the Atlantic with our Canadian friends," stated Alexandre Krivine, president and CEO of 3S PHOTONICS.

The share purchase agreement follows Avensys Corporation's announcement earlier this year of the hiring of a financial advisory firm to assist the company in reviewing and evaluating its financial and strategic alternatives.

Source: http://www.avensyscorporation.com/Home.php

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.